Tunisian Lung Cancer Registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter, national observational registry enrolling adults with histologically or cytologically confirmed lung cancer. Patients are recruited consecutively from pulmonology, medical oncology, radiation oncology, and thoracic surgery departments, and data on clinical features, treatments, and disease course are recorded. Eligibility requires diagnosis confirmed at least three months before inclusion and written informed consent, with no experimental interventions assigned by the registry. The effort is coordinated by Dacima Consulting together with national professional societies and hospital teams to create a representative picture of lung cancer care across Tunisia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age more than 18 years
* Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
* Informed consent

Exclusion Criteria:

* None

Where it's running

• Tunisian Society of Respiratory Diseases and Allergology
  Tunis, Tunisia Recruiting
• Tunisian Society of Medical Oncology
  Aryanah, Tunisia Not yet recruiting

Study contacts

• Study coordinator: Soraya Fenniche, MD
• Email: soraya.fenniche@yahoo.fr
• Phone: +216 98 586 490

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enhanced COPD care for people being checked for lung cancer

  This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.

  Recruiting Region of Southern Denmark · Vejle · NCT07543601

• New blood test that detects cancer by measuring glycosidase enzyme activity with volatile ethanol probes.

  This pilot will test whether a blood test using volatile probes that release ethanol can detect localized breast, lung, and pancreatic cancers in patients scheduled for surgery.

  Recruiting Early Phase 1 Poitiers University Hospital · Poitiers · NCT07236177

• Using MRI to improve diagnosis of brain damage from lung cancer treatment

  This study tests a new MRI method to see if it can better diagnose brain damage in lung cancer patients who have had radiation treatment and are facing complications.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT05977803

• Innovative care program for lung cancer survivors

  This study is testing a new care program designed to help lung cancer survivors in Kentucky feel better and improve their quality of life compared to standard care.

  Recruiting University of Kentucky · Lexington, Kentucky · NCT05857995

• Erector spinae block for pain management in thoracic surgery

  This study is testing if a special pain relief technique using erector spinae blocks can help patients having lung surgery feel less pain and need fewer pain medications after their operation.

  Recruiting Phase 4 George Washington University · Washington D.C., District of Columbia · NCT05521789

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.